Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Genky DrugStores Co., Ltd. ( (JP:9267) ) has provided an announcement.
Genky DrugStores reported robust April performance for the fiscal year ending June 2026, with all-store net sales up 9.4% year on year and existing-store sales up 1.7%. Customer traffic at existing stores rose 2.1% while spending per customer edged down 0.5%, indicating growth driven mainly by increased footfall rather than higher basket sizes.
The company continued its aggressive expansion and standardization strategy, opening six new regular-format stores in April, refurbishing three outlets into standardized regular stores and closing none, bringing its total network to 516 locations. Cumulatively for the current fiscal year, all-store sales are up 9.6% and existing-store sales up 2.8%, underscoring sustained top-line momentum and a strengthening competitive position in Japan’s drugstore sector despite modest pressure on per-customer spending.
More about Genky DrugStores Co., Ltd.
Genky DrugStores Co., Ltd. is a Japan-based drugstore operator listed on the Tokyo Stock Exchange Prime market, focusing on standardized 300-tsubo regular stores. The company operates a broad network of retail outlets that sell pharmaceuticals, daily necessities and related products, with a strategy centered on store standardization and steady network expansion in its domestic market.
Average Trading Volume: 76,470
Technical Sentiment Signal: Hold
Current Market Cap: Yen118.9B
For detailed information about 9267 stock, go to TipRanks’ Stock Analysis page.